We are live on
!
Find out more
PCM
Parsons Capital Management Portfolio holdings
AUM
$2.21B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+395.61%
AUM
$914M
AUM Growth
+$100M
(+12%)
Cap. Flow
-$3.09M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
31.86%
Holding
350
New
17
Increased
97
Reduced
173
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.18M |
| 2 |
Boeing
BA
|
+$1.21M |
| 3 |
Alibaba
BABA
|
+$764K |
| 4 |
Walt Disney
DIS
|
+$745K |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$682K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.61M |
| 3 |
NXP Semiconductors
NXPI
|
+$980K |
| 4 |
3M
MMM
|
+$784K |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$777K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Industrials | 14.5% |
| 3 | Healthcare | 13.1% |
| 4 | Financials | 11.79% |
| 5 | Consumer Discretionary | 6.71% |
Similar funds
BOI
WCMNY
NLGIA
ML
IFA
DPCM
RAM
CFM
Parsons Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Parsons Capital Management held 350 positions worth $914M, up 12% from $813M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parsons Capital Management's Q1 2019 filing shows 17 new, 97 increased, 173 reduced and 4 closed positions. Its largest new stake was Elanco Animal Health: 13,466 shares worth $432K. The largest sale was CVS Health, an estimated $2.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
- Parsons Capital Management's largest Q1 2019 buy was Elanco Animal Health: 13,466 shares worth $432K.
- Parsons Capital Management added most to Celgene Corp in Q1 2019, an estimated $2.18M increase.
- Parsons Capital Management's biggest Q1 2019 reduction was CVS Health, cutting an estimated $2.5M.
- Parsons Capital Management fully exited Biogen in Q1 2019, selling an estimated $536K.
- Parsons Capital Management's ten largest holdings make up 32% of its $914M portfolio in Q1 2019.
- Parsons Capital Management opened 17 new positions and closed 4 in Q1 2019.
- Parsons Capital Management's portfolio value rose 12% quarter-over-quarter to $914M.
Based on Parsons Capital Management's 13F filing for Q1 2019, filed 26 Apr 2019.